Table 2.
Treatment regimens and allograft survivals
| Animal No. | Treatment
|
Islet | Kidney | Comments | |||
|---|---|---|---|---|---|---|---|
| ATG | CD40 | Tac/Rapa | Rapa | ||||
| M3513 | + | + | 1 PELF | >19 | 2 CMV (19 3 POD) | ||
| M3213 | + | + | 1 PELF | >26 | 2 CMV (26 3 POD) | ||
| M5113 | + | + | 90 | >120 | Kidney: No rejection | ||
| M5813 | + | + | 94 | 98 | 4 ABMR | ||
| M7113 | + | + | >120 | >120 | Both: No rejection | ||
| M6813 | + | + | >120 | >120 | Both: No rejection | ||
| M2414 | + | + | >120 | >120 | Both: No rejection | ||
| M4514 | + | + | - | >120 | No rejection | ||
| M3115 | + | + | - | >120 | No rejection | ||
| M2815 | + | + | - | >120 | No rejection | ||
| M4315 | + | + | - | >120 | No rejection | ||
1
Partial Engraftment with Limited Function,
2
Cytomegalovirus pneumonia,
3
Post Operative Day,
4
Antibody Mediated Rejection